Mapping the precise cellular and molecular landscape of breast tissue in the context of an evolving physiology has shed light into potential driving factors responsible for breast cancer risk and progression; including the role of serum estrogens, leptin and adiponectin imbalances, mammogram density, insulin deregulation pathways and chronic inflammation. Here, ADIPOQ is linked to breast cancer.